Clinical Trial Update: A Study of FZ-AD005 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 study evaluating FZ-AD005 in adults with advanced solid tumors, including small cell lung cancer and large cell neuroendocrine carcinoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Neuroendocrine Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• FZ-AD005

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma) | Phase 1 | Status: RECRUITING